TITLE

Chemical Genomics Is the "Big Tent" of Drug Discovery

AUTHOR(S)
DePalma, Angelo
PUB. DATE
October 2004
SOURCE
Drug Discovery & Development;Oct2004, Vol. 7 Issue 10, p51
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Discusses the significance of chemical genomics in drug discovery. Popularity of classical chemical genomics; Terminologies related to chemical genomics; Detection of targets for drugs rather than drugs for targets; Screening of proteins; Fragment-based approach. INSETS: Back to Nature;NH Funds Chemical Genomics Initiative.
ACCESSION #
14762916

 

Related Articles

  • Genotyping of Three Single Nucleotide Polymorphisms Following Whole Genome Preamplification of DNA Collected from Buccal Cells. Haaberstick, Brett C.; Smolen, Andrew // Behavior Genetics;Sep2004, Vol. 34 Issue 5, p541 

    Collection of genomic DNA from buccal cells is a simple and convenient procedure for genotyping individuals. One disadvantage is that the amount of genomic DNA may be inadequate for genotyping projects that require a large number of determinations per sample. Primer Extension Preamplification...

  • Interaction preferences across protein-protein interfaces of obligatory and non-obligatory components are different. De, Subhajyoti; Krishnadev, O.; Srinivasan, N.; Rekha, N. // BMC Structural Biology;2005, Vol. 5, p15 

    Background: A polypeptide chain of a protein-protein complex is said to be obligatory if it is bound to another chain throughout its functional lifetime. Such a chain might not adopt the native fold in the unbound form. A non-obligatory polypeptide chain associates with another chain and...

  • Maintenance of mitochondrial DNA integrity: repair and degradation. Kang, Dongchon; Hamasaki, Naotaka // Current Genetics;May2002, Vol. 41 Issue 5, p311 

    Mitochondria have their own genome, which is essential for proper oxidative phosphorylation and hence for a large part of ATP production in a cell. Although mitochondrial DNA-less (rho0) cells can survive under certain conditions, the integrity of the mitochondrial genome is critical for the...

  • The Seattle Structural Genomics Center for Infectious Disease (SSGCID). Myler, P. J.; Stacy, R.; Stewart, L.; Staker, B. L.; Voorhis, W. C. Van; Varani, G.; Buchko, G. W. // Infectious Disorders - Drug Targets;Oct2009, Vol. 9 Issue 5, p493 

    The NIAID-funded Seattle Structural Genomics Center for Infectious Disease (SSGCID) is a consortium established to apply structural genomics approaches to potential drug targets from NIAID priority organisms for biodefense and emerging and re-emerging diseases. The mission of the SSGCID is to...

  • Protozoan genomics for drug discovery. Chaudhary, Kshitiz; Roos, David S. // Nature Biotechnology;Sep2005, Vol. 23 Issue 9, p1089 

    The article focuses on the utilization of protozoan genomics for development of new drugs. Of the ten diseases targeted as research priorities by the World Health Organization's Special Program for Research and Training in Tropical Diseases, one is caused by a virus, two by bacterial pathogens,...

  • Expression profiling identifies novel candidate genes for ethanol sensitivity QTLs. MacLaren, Erik J.; Bennett, Beth; Johnson, Thomas E.; Sikela, James M. // Mammalian Genome;Feb2006, Vol. 17 Issue 2, p147 

    The Inbred Long Sleep (ILS) and Inbred Short Sleep (ISS) mouse strains have a 16-fold difference in duration of loss of the righting response (LORR) following administration of a sedative dose of ethanol. Four quantitative trait loci (QTLs) have been mapped in these strains for this trait....

  • A Defining Moment for Chemical Genomics. Shaw, Gina // Drug Discovery & Development;Apr2005, Vol. 8 Issue 4, p45 

    Looks into the interest of the pharmaceutical industry on chemical genomics in drug development. Significance of chemical genomics in allowing scientists to rapidly characterize a large pool of small molecules against target proteins; Move of several companies to enter the research focusing on...

  • What's in the 'junk' of the genome? Kiermer, Veronique // Nature Methods;May2005, Vol. 2 Issue 5, p328 

    A large-scale analysis of the human transcriptome with unprecedented resolution raises the possibility that large numbers of transcripts are produced from regions of the genome considered as intergenic in the current annotation.

  • Editorial [Hot Topic: Structure-Based Virtual Ligand Screening (Guest Editor: Bruno O. Villoutreix)]. Villoutreix, Bruno O. // Current Protein & Peptide Science;Oct2006, Vol. 7 Issue 5, p367 

    The last two decades have witnessed the dawn of a new era of “in silico-based” biology. These methods have been playing a major role, from investigation of the genomes to the design of new therapeutic compounds or prediction of protein structures. Lately, as computer technology has...

Share

Other Topics